Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.

N. L. Haigwood, L. Misher, S. M. Chin, M. Blair, V. Planelles, C. J. Scandella, K. S. Steimer, M. B. Gardner, T. Yilma, V. M. Hirsch

    Research output: Contribution to journalArticle

    14 Scopus citations

    Abstract

    Sera from SIV-infected macaques were found to contain antibodies that reacted with conformation-dependent, group-specific determinants on the SIV envelope protein gp130. These conformation-dependent antibodies exhibited virus neutralizing activity; their presence was associated with protection in vaccine studies. The properties of these antibodies are quite similar to those that have been identified in sera from HIV-infected human subjects. These data suggest that the SIV envelope gp130 remains a candidate for subunit vaccine studies.

    Original languageEnglish (US)
    Pages (from-to)82-90
    Number of pages9
    JournalJournal of medical primatology
    Volume21
    Issue number2-3
    StatePublished - Jan 1 1992

    ASJC Scopus subject areas

    • Animal Science and Zoology
    • veterinary(all)

    Fingerprint Dive into the research topics of 'Characterization of group specific antibodies in primates: studies with SIV envelope in macaques.'. Together they form a unique fingerprint.

  • Cite this

    Haigwood, N. L., Misher, L., Chin, S. M., Blair, M., Planelles, V., Scandella, C. J., Steimer, K. S., Gardner, M. B., Yilma, T., & Hirsch, V. M. (1992). Characterization of group specific antibodies in primates: studies with SIV envelope in macaques. Journal of medical primatology, 21(2-3), 82-90.